Abstract
Purpose
Obstructive sleep apnea (OSA) is highly associated with type 2 diabetes mellitus (DM), and treatment of OSA may have a positive impact on cardiometabolic profile. This study investigates the effects of continuous positive airway pressure (CPAP) treatment on glycemic control and cardiometabolic parameters in patients with diabetes.
Methods
Diabetic patients, who were newly diagnosed of OSA with an apnea hypopnea index (AHI) ≥15 and HbA1c ≥7%, were randomly assigned to either CPAP treatment or no treatment (control) for 3 months. Measurements included HbA1c, blood pressure, fasting glucose and lipids, urinary albumin, and peripheral arterial tonometry (to assess endothelial function).
Results
Sixty-four patients (52 men) were randomized, with mean (±SD) age of 55.0 ± 9.6 years, body mass index of 29.9 ± 5.3 kg/m2, HbA1c of 8.1 ± 1.1%, and AHI of 45.3 ± 23.2 events/h. In the intention-to-treat analysis, no significant change in HbA1c but reduction of systolic (10 mmHg (−18 to −2), p < 0.05) and diastolic (6 mmHg (−11 to −1), p < 0.05) blood pressures were found in the CPAP group compared to the control group. Excluding those with medication changes or initiated dietary program during the study period and those who dropped out, CPAP treatment decreased HbA1c (intervention group, n = 27; control group, n = 26) by 0.4% (−0.7 to −0.1), p = 0.027.
Conclusions
In patients with type 2 DM and moderate to severe OSA, 3 months of CPAP therapy did not decrease HbA1c but lowered systolic and diastolic blood pressures. In view of a potentially limited effect size of CPAP treatment on glycemic control, sample size estimation for future randomized controlled studies must make adequate allowance for influence from external factors of medications/diet and CPAP use.
Similar content being viewed by others
Abbreviations
- AHI:
-
Apnea hypopnea index
- CPAP:
-
Continuous positive airway pressure
- DM:
-
Diabetes mellitus
- ESS:
-
Epworth Sleepiness Scale
- HbA1c:
-
Glycated hemoglobin
- ITT:
-
Intention-to-treat
- OSA:
-
Obstructive sleep apnea
- PAT:
-
Peripheral arterial tonometry
- PSG:
-
Polysomnography
- RCT:
-
Randomized controlled trial
References
Idris I, Happ AP, O’Reilly J, Barnett A, Allen M, Andrews R, Grunstein P, Lewis K, Goenka N, Wilding JP (2009) Obstructive sleep apnoea in patients with type 2 diabetes: aetiology and implications for clinical care. Diabetes Obes Metab 11:733–741. doi:10.1111/j.1463-1326.2009.01045.x
Shaw JE, Punjabi NM, Wilding JP, Alberti KGMM, Zimmet PZ (2008) Sleep-disordered breathing and type 2 diabetes. A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pr 81:2–12. doi:10.1016/j.diabres.2008.04.025
West SD, Nicoll DJ, Stradling JR (2006) Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 61:945–950. doi:10.1136/thx.2005.057745
Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, Wadden TA, Kelley D, Wing RR, Sunyer FX, Darcey V, Kuna ST, Sleep AHEAD Research Group (2009) The Sleep AHEAD Research Group. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 32:1017–1019. doi:10.2337/dc08-1776
Lam DC, Lui MM, Lam JC, Ong LH, Lam KS, Ip MS (2010) Prevalence and recognition of obstructive sleep apnea in Chinese patients with type 2 diabetes mellitus. Chest 138:1101–1107. doi:10.1378/chest.10-0596
Schober AK, Neurath MF, Harsch IA (2011) Prevalence of sleep apnoea in diabetic patients. Clin Respir J 5:165–172. doi:10.1111/j.1752-699X.2010.00216.x
Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK (2009) Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 122:1122–1127. doi:10.1016/j.amjmed.2009.04.026
Kent BD, Grote L, Ryan S, Pepin JL, Bonsignore MR, Tkacova R, Saaresranta T, Verbraecken J, Lévy P, Hedner J, McNicholas WT, ESADA collaborators (2014) Diabetes mellitus prevalence and control in sleep disordered breathing: the European Sleep Apnea Cohort (ESADA) study. Chest 146:982–990. doi:10.1378/chest.13-2403
Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G (2013) Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol 62(7):569–576. doi:10.1016/j.jacc.2013.05.045
Yang D, Liu Z, Yang H, Luo Q (2013) Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 17(1):33–38. doi:10.1007/s11325-012-0680-8
Kendzerska T, Gershon AS, Hawker G, Tomlinson G, Leung RS (2014) Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Resp Crit Care 190:218–225. doi:10.1164/rccm.201312-2209OC
Aronsohn RS, Whitmore H, Van Cauter E, Tasali E (2010) Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Resp Crit Care 181:507–513. doi:10.1164/rccm.200909-1423OC
Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B (2005) The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 9:176–180
West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR (2007) Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnea and type 2 diabetes. Thorax 62:969–974. doi:10.1136/thx.2006.074351
Dawson A, Abel SL, Loving RT, Dailey G, Shadan FF, Cronin JW, Kripke DF, Kline LE (2008) CPAP therapy of obstructive sleep apnea in type 2 diabetic improves glycemic control during sleep. J Clin Sleep Med 4:538–542
Prasad B, Carley DW, Krishnan JA, Weaver TE, Weaver FM (2012) Effects of positive airway pressure treatment on clinical measures of hypertension and type 2 diabetes. J Clin Sleep Med 8:481–487. doi:10.5664/jcsm.2136
Myhill PC, Davis WA, Peters KE, Chubb SA, Hillman D, Davis TM (2012) Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. J Clin Endocr Metab 97:4212–4218. doi:10.1210/jc.2012-2107
Shaw JE, Punjabi NM, Naughton MT, Willes L, Bergenstal RM, Cistulli PA, Fulcher GR, Richards GN, Zimmet PZ. (2016) The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. Am J Resp Crit Care 2016 Feb 29. doi: 10.1164/rccm.201511-2260OC
Martínez-Cerón E, Barquiel B, Bezos AM, Casitas R, Galera R, García-Benito C, Hernanz A, Alonso-Fernández A, Garcia-Rio F. (2016) Effect of CPAP on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. A randomized clinical trial. Am J Resp Crit Care 2016 Feb 24. doi: 10.1164/rccm.201510-1942OC
Hamburg NM, Palmisano J, Larson MG, Sullivan LM, Lehman BT, Vasan RS, Levy D, Mitchell GF, Vita JA, Benjamin EJ (2011) Relation of brachial and digital measures of vascular function in the community: the Framingham Heart Study. Hypertension 57:390–396. doi:10.1161/HYPERTENSIONAHA.110.160812
Lui MM, Mak JC, Lai AY, Hui CK, Lam JC, Lam DC, Ip MS (2016) The impact of obstructive sleep apnea and tobacco smoking on endothelial function. Respiration 91(2):124–131. doi:10.1159/000443527
Iftikhar IH, Blankfield RP (2012) Effect of continuous positive airway pressure on hemoglobin A1c in patients with obstructive sleep apnea: a systemic review and meta-analysis. Lung 190:605–611. doi:10.1007/s00408-012-9404-x
Pamidi S, Wroblewski K, Stepien M, Sharif-Sidi K, Kilkus J, Whitmore H, Tasali E (2015) Eight hours of nightly CPAP treatment of obstructive sleep apnea improves glucose metabolism in prediabetes: a randomized controlled trial. Am J Resp Crit Care 192(1):96–105. doi:10.1164/rccm.201408-1564OC
Lam JCM, Lam B, Yao TJ, Lai AYK, Ooi CG, Tam S, Lam KS, Ip MS (2010) A randomized controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J 35:138–145. doi:10.1183/09031936.00047709
Tachikawa R, Ikeda K, Minami T, Matsumoto T, Hamada S, Murase K, Tanizawa K, Inouchi M, Oga T, Akamizu T, Mishima M, Chin K. (2016) Changes in energy metabolism after continuous positive airway pressure for obstructive sleep apnea. Am J Resp Crit Care 2016 Mar 1. doi: 10.1164/rccm.201511-2314OC
American Diabetes Association (2003) Treatment of hypertension in adults with diabetes. Diabetes Care 26:80S–82S. doi:10.2337/diacare.26.2007.S80
Eguchi K, Pickering TG, Kario K (2007) Why is blood pressure so hard to control in patients with type 2 diabetes? Journal of the cardiometabolic syndrome 2:114–118. doi:10.1111/j.1559-4564.2007.06124.x
Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, Lévy P, Riha R, Bassetti C, Narkiewicz K, Mancia G, McNicholas WT, EU COST Action B26 members (2013) ERS/ESH Task Force Report. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 41:523–538. doi:10.1183/09031936.00226711
Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, Lima-Alvarez J, Benitez MA, Almeida-Gonzalez C (2007) Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 132:1847–1852. doi:10.1378/chest.07-1478
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ, American Heart Association; American Diabetes Association (2007) Primary prevention of cardiovascular diseases in people with diabetes mellitus—a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 30:162–172. doi:10.2337/dc07-9917
Goff DC, Gerstein HC, Ginsberg HN, Cushman WC, Margolis KL, Byington RP, Buse JB, Genuth S, Probstfield JL, Simons-Morton DG, ACCORD Study Group (2007) Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the action to control cardiovascular risk in diabetes (ACCORD) trial. Am J Cardiol 99(suppla):4i–20i. doi:10.1016/j.amjcard.2007.03.002
Chirinos JA, Gurubhagavatula I, Teff K, Rader DJ, Wadden TA, Townsend R, Foster GD, Maislin G, Saif H, Broderick P, Chittams J, Hanlon AL, Pack AI (2014) CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 370:2265–2275. doi:10.1056/NEJMoa1306187
Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, Kader G, Mahowald M, Younger J, Pack AI (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30:711–719
Lui MM, Ip S-M (2012) OSA and atherosclerosis. Journal of Thoracic Disease 4(2):164–172. doi:10.3978/j.issn.2072-1439.2012.01.06
Lai AY, Fong DY, Lam JC, Weaver TE, Ip MS (2014) The efficacy of a brief motivational enhancement education program on CPAP adherence in OSA: a randomized controlled trial. Chest 146(3):600–610. doi:10.1378/chest.13-2228
Acknowledgments
We thank Ms. Michelle Cheong, Ms. Peony Chong and Mr. Kelvin Lau for research assistance and all the clinical staff at the Ho Ting Sik Sleep Disorders Center, Queen Mary Hospital, for patient care during sleep studies and CPAP titration/monitoring.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The Department of Medicine, The University of Hong Kong, provided financial support in the form of Lee Wing Tat Cardiopulmonary Research Fund. The funding source had no role in the design or conduct of this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Clinical trial registration
www.clinicaltrials.gov (NCT 00876980)
Rights and permissions
About this article
Cite this article
Lam, J.C.M., Lai, A.Y.K., Tam, T.C.C. et al. CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure. Sleep Breath 21, 377–386 (2017). https://doi.org/10.1007/s11325-016-1428-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-016-1428-7